Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy
about
Fluorescent and Bioluminescent Reporter MyxovirusesEvolving treatment paradigms for chemotherapy-induced nausea and vomitingNon-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and DexamethasoneMode of parainfluenza virus transmission determines the dynamics of primary infection and protection from reinfectionVisualizing real-time influenza virus infection, transmission and protection in ferrets.In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.Anticipatory nausea and vomiting due to chemotherapy.A novel reporter system for neutralizing and enhancing antibody assay against dengue virusRelationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging studyTRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 PolymeraseSendai virus-based RSV vaccine protects African green monkeys from RSV infection.Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets.Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.The Emerging Duck Flavivirus Is Not Pathogenic for Primates and Is Highly Sensitive to Mammalian Interferon Antiviral Signaling.Sendai virus as a backbone for vaccines against RSV and other human paramyxovirusesHighly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells.Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.Visualizing the replication of respiratory syncytial virus in cells and in living mice.Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Dynamics of Sendai virus spread, clearance, and immunotherapeutic efficacy after hematopoietic cell transplant imaged non-invasively in mice.Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds.A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing LuciferaseDirected evolution of an influenza reporter virus to restore replication and virulence and enhance non-invasive bioluminescence imaging in miceClinical and Molecular Epidemiology of Human Parainfluenza Viruses 1-4 in Children from Viet Nam
P2860
Q26741398-02BC0BC8-084C-4129-B663-BF75DB1B96EEQ27024463-53BB729C-3E60-492B-A588-E841EFE03087Q27312086-0AA05FE0-1EAB-4F67-97CB-EE9AE7DABF43Q27331956-68CDD0D8-13C4-4C8F-BF8C-3F6EF01A593BQ30372454-A5326824-F19A-44F9-BBC4-DC32964D95D1Q30430923-E7DFF37D-DF1B-43AD-9406-94088D152F0CQ34038675-3F590A3E-1AD5-4359-B1BE-7389D763A928Q35096730-4758655D-7289-4E78-B40C-EB3DD9FA8CAEQ35487966-80ADDDEC-4C75-4A29-9CB5-7ABD813DF0A6Q35658224-27777238-8A40-4490-8322-286B981E960FQ35667184-01355713-1301-41D3-9CBE-40B1844B2D9BQ36365747-BE9E8BE7-D43C-4AEB-AA65-88EAC07228B1Q36827280-7BC11C14-FF7B-49B5-AAF1-63A20A7ADCF0Q37073267-31EF2393-C189-489E-BE30-34297F1C3F26Q37118707-E4BA0C09-BF2F-4285-8C3A-CC983B70CE13Q37336673-FA31016D-E628-42C3-87DD-D60B376CA770Q37609798-DAB1EF4B-76B6-45BE-907E-CBC50B2DE572Q37690397-26217CE8-FA06-4AC0-9C75-C4712A53DEB0Q37713874-2DD30041-12D5-4C22-92DE-6E034AE75A18Q39789095-94E96E4E-072D-4F5A-8EFE-8E4D50058BD7Q40231964-24486D58-C00E-4DE6-BFD6-EAA1E20C4B26Q41718495-A26E10D2-B2C4-44AE-A885-C40B39DDD9B7Q41873413-8DC0744F-12E6-46EF-934E-65E26D6A63ADQ45325417-8BBD08EF-297E-448B-BBC6-DCE292FDD70BQ52664407-17FAFC4B-EB8A-4BC5-86B0-2D78E34D5950Q56477377-EF763040-400E-4395-AF3D-5DC4A6CEEFDFQ56890034-B25CD1F3-5433-4E94-889A-F8821F10715DQ57021778-3D085D51-2D12-4667-B288-889C9149C2E1
P2860
Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@ast
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@en
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@nl
type
label
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@ast
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@en
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@nl
prefLabel
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@ast
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@en
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@nl
P2093
P2860
P3181
P1433
P1476
Illumination of parainfluenza ...... ls a tissue-specific dichotomy
@en
P2093
Bart G Jones
Charles J Russell
Emilie Dalloneau
John N Mason
Julia L Hurwitz
Sherri L Surman
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002134
P407
P577
2011-07-07T00:00:00Z